TEEB@Yale – Valuing nature for policy, business and people
During his tenure as McCluskey Fellow at Yale University’s School of Forestry and Environmental Studies in 2011, GIST Impact CEO and TEEB Study Leader Pavan Sukhdev led a graduate-level course on The Economics of Ecosystems and Biodiversity (TEEB). TEEB—an initiative supported by the European Commission and the Government of Germany, and later hosted by the […]
Bridging the Gap: Social and Financial Disclosures in an Era of Growing Inequality
A practical guide to nature-related metrics, reporting requirements, and legal implications from our SVP, Commercial Development, Mahima Sukhdev.
Biodiversity in the Boardroom
A practical guide to nature-related metrics, reporting requirements, and legal implications from our SVP, Commercial Development, Mahima Sukhdev.
Measuring the biodiversity footprint of a well-known financial index (and its peers)
Introduction In our previous post, GIST Impact analysed the climate, nature and biodiversity risks of one of the world’s most well-known indices. This index serves as the benchmark for ca. USD 5 trillion in assets under management, covering approximately 85% of the global investable equities across 20+ developed markets and 20+ emerging markets countries. GIST […]
Bridging the Gap: Social and Financial Disclosures in an Era of Growing Inequality
Despite growing interest in ESG, one piece remains persistently underdeveloped: the “S”. Inequality, labour rights, and community well-being are still too often treated as secondary concerns in sustainability reporting – measured through intent, not outcomes. But with geopolitical instability rising, and social unrest linked directly to declining trust and opportunity, that approach is no longer […]
Deeper Than Disclosure: The New ESG Frontier with AI
How well do you trust AI to deliver useful and reliable ESG insights? As regulations evolve and complexity grows, many companies are turning to AI — but not AI is created equal. This report explores how GIST Impact’s AI goes beyond surface-level disclosures to uncover deeper, decision-ready insights on a company’s real impacts, risks, and opportunities. […]
The climate, nature and biodiversity risks of a well-known index
Introduction GIST Impact has analysed one of the world’s most well-known indices, serving as the benchmark for ca. USD 5 trillion in assets under management. The index is a mirror to the world – covering approximately 85% of the global investable equities across 20+ developed markets and 20+ emerging markets countries. But how good is […]
Integrated Profit and Loss Reporting
This blog post refers to a paper published in 2018 by the Stockholm Resilience Centre – demonstrating our long-standing expertise in impact accounting and framework development. Understanding the full spectrum of corporate performance goes beyond financial statements. The “Integrated Profit & Loss Reporting” framework is designed to measure the impacts of business activities not just […]
Impact Valuation Sprint Report
GIST Impact was delighted to contribute to the “Impact Valuation Sprint Report,” coordinated by the Value Balancing Alliance and launched in May 2024.
Industry reveal: What is the natural capital impact of the top pharmaceutical companies?
We recently looked at the top pharmaceutical companies across developed markets to assess how successful they’ve been in reducing their natural capital impacts. Our analysis found that only 3 of the largest companies (by revenue) in developed markets outperformed the sector average in terms of reducing their overall natural capital impacts (measured by impact intensities […]
